One issue related to human cancers with R132H mutations is that numerous studies have shown that more 2HG is produced if the cells are heterozygous (wild-type IDH1/R132H) compared to cells that are homozygous R132H [52,53] One possible explanation is that a mixture of homodimeric and heterodimeric enzymes form. This evidence concerns the gene IDH1 and cancer.